Works matching DE "MARAVIROC (Drug)"

Results: 186
    1
    2

    Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease Model.

    Published in:
    Cancers, 2021, v. 13, n. 19, p. 4935, doi. 10.3390/cancers13194935
    By:
    • Passman, Adam M.;
    • Strauss, Robyn P.;
    • McSpadden, Sarah B.;
    • Finch-Edmondson, Megan;
    • Andrewartha, Neil;
    • Woo, Ken H.;
    • Diepeveen, Luke A.;
    • Zhao, Weihao;
    • Fernández-Irigoyen, Joaquín;
    • Santamaría, Enrique;
    • Medina-Ruiz, Laura;
    • Szpakowska, Martyna;
    • Chevigné, Andy;
    • Park, Hyerin;
    • Carlessi, Rodrigo;
    • Tirnitz-Parker, Janina E. E.;
    • Blanco, José R.;
    • London, Roslyn;
    • Callus, Bernard A.;
    • Elsegood, Caryn L.
    Publication type:
    Article
    3
    4

    Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.

    Published in:
    International Journal of STD & AIDS, 2012, v. 23, n. 7, p. 459, doi. 10.1258/ijsa.2012.011391
    By:
    • Bucciardini, R.;
    • D'Ettorre, G.;
    • Baroncelli, S.;
    • Ceccarelli, G.;
    • Parruti, G.;
    • Weimer, L. E.;
    • Fragola, V.;
    • Galluzzo, C. M.;
    • Pirillo, M. F.;
    • Lucattini, S.;
    • Bellagamba, R.;
    • Francisci, D.;
    • Ladisa, N.;
    • Antoni, A. Degli;
    • Guaraldi, G.;
    • Manconi, P. E.;
    • Vullo, V.;
    • Preziosi, R.;
    • Cirioni, O.;
    • Verucchi, G.
    Publication type:
    Article
    5
    6

    Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).

    Published in:
    2017
    By:
    • Gulick, Roy M.;
    • Wilkin, Timothy J.;
    • Chen, Ying Q.;
    • Landovitz, Raphael J.;
    • Amico, K. Rivet;
    • Young, Alicia M.;
    • Richardson, Paul;
    • Marzinke, Mark A.;
    • Hendrix, Craig W.;
    • Eshleman, Susan H.;
    • McGowan, Ian;
    • Cottle, Leslie M.;
    • Andrade, Adriana;
    • Marcus, Cheryl;
    • Klingman, Karin L.;
    • Chege, Wairimu;
    • Rinehart, Alex R.;
    • Rooney, James F.;
    • Andrew, Philip;
    • Salata, Robert A.
    Publication type:
    journal article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Blocking CCR5.

    Published in:
    Nature Structural & Molecular Biology, 2013, v. 20, n. 10, p. 1145, doi. 10.1038/nsmb.2693
    By:
    • Chen, Inês
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    Not Recommended, But Done: Breastfeeding with HIV in Germany.

    Published in:
    AIDS Patient Care & STDs, 2021, v. 35, n. 2, p. 33, doi. 10.1089/apc.2020.0223
    By:
    • Haberl, Lila;
    • Audebert, Franz;
    • Feiterna-Sperling, Cornelia;
    • Gillor, Daniel;
    • Jakubowski, Peter;
    • Jonsson-Oldenbüttel, Celia;
    • Khaykin, Pavel;
    • Kiener, Rita;
    • Reitter, Anke;
    • Rieke, Ansgar;
    • Rodríguez, Elena;
    • Rößler, Steve;
    • Rump, Jörg-Andres;
    • Schüttfort, Gundolf;
    • Stephan, Christoph;
    • Ulmer, Albrecht;
    • von Braun, Amrei;
    • von Weizsäcker, Katharina;
    • Haberl, Annette
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31

    Interactions between Alcohol and the HIV Entry Inhibitor Maraviroc.

    Published in:
    Journal of the International Association of Providers of AIDS Care, 2013, v. 12, n. 6, p. 375, doi. 10.1177/2325957413495567
    By:
    • Gruber, Valerie A.;
    • Rainey, Petrie M.;
    • Lum, Paula J.;
    • Beatty, George W.;
    • Aweeka, Francesca T.;
    • McCance-Katz, Elinore F.
    Publication type:
    Article
    32
    33

    No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects.

    Published in:
    Journal of Clinical Pharmacology, 2019, v. 59, n. 1, p. 139, doi. 10.1002/jcph.1306
    By:
    • Vourvahis, Manoli;
    • Smith, Kimberly Y.;
    • Heera, Jayvant;
    • McFadyen, Lynn;
    • Chan, Phylinda L. S.;
    • Nepal, Sunil;
    • Valluri, Srinivas Rao;
    • Fang, Annie;
    • Fate, Gwendolyn D.;
    • Wood, Linda S.;
    • Marshall, Jean‐Claude;
    • Nedderman, Angus;
    • Haynes, Julian;
    • Savage, Mark E.;
    • Clark, Andrew
    Publication type:
    Article
    34
    35

    Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study

    Published in:
    Clinical Infectious Diseases, 2016, v. 63, n. 1, p. 122, doi. 10.1093/cid/ciw207
    By:
    • Pett, Sarah Lilian;
    • Amin, Janaki;
    • Horban, Andrejz;
    • Andrade-Villanueva, Jaime;
    • Losso, Marcelo;
    • Porteiro, Norma;
    • Madero, Juan Sierra;
    • Belloso, Waldo;
    • Tu, Elise;
    • Silk, David;
    • Kelleher, Anthony;
    • Harrigan, Richard;
    • Clark, Andrew;
    • Wataru Sugiura;
    • Wolff, Marcelo;
    • Gill, John;
    • Gatell, Jose;
    • Fisher, Martin;
    • Clarke, Amanda;
    • Ruxrungtham, Kiat
    Publication type:
    Article
    36

    Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

    Published in:
    Clinical Infectious Diseases, 2015, v. 61, n. 10, p. 1582, doi. 10.1093/cid/civ587
    By:
    • Colbers, Angela;
    • Best, Brookie;
    • Schalkwijk, Stein;
    • Jiajia Wang;
    • Stek, Alice;
    • Tenorio, Carmen Hidalgo;
    • Hawkins, David;
    • Taylor, Graham;
    • Kreitchmann, Regis;
    • Burchett, Sandra;
    • Haberl, Annette;
    • Kabeya, Kabamba;
    • van Kasteren, Marjo;
    • Smith, Elizabeth;
    • Capparelli, Edmund;
    • Burger, David;
    • Mirochnick, Mark
    Publication type:
    Article
    37
    38
    39
    40
    41

    Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy.

    Published in:
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, v. 31, n. 8, p. 2083, doi. 10.1007/s10096-012-1546-5
    By:
    • Macías, J.;
    • Viloria, M.;
    • Rivero, A.;
    • Santos, I.;
    • Márquez, M.;
    • Portilla, J.;
    • Di Lello, F.;
    • Camacho, A.;
    • Sanz-Sanz, J.;
    • Ojeda, G.;
    • Mata, R.;
    • Gómez-Mateos, J.;
    • Pineda, J.
    Publication type:
    Article
    42

    Network meta‐analysis of post‐exposure prophylaxis randomized clinical trials.

    Published in:
    HIV Medicine, 2021, v. 22, n. 3, p. 218, doi. 10.1111/hiv.12964
    By:
    • Fernández, I;
    • Lazzari, E.;
    • Inciarte, A.;
    • Diaz‐Brito, V.;
    • Milinkovic, A.;
    • Arenas‐Pinto, A.;
    • Etcheverrry, F.;
    • García, F.;
    • Leal, L;
    • Fernandez, E;
    • Gonzalez, E;
    • Lucero, C;
    • Leon, A;
    • Garcıa, F;
    • Manzardo, C;
    • Nicolas, D;
    • Bodro, M;
    • del Rıo, A;
    • Cardozo, C;
    • Cervera, C
    Publication type:
    Article
    43

    Week 96 results of the randomized, multicentre Maraviroc Switch ( MARCH) study.

    Published in:
    HIV Medicine, 2018, v. 19, n. 1, p. 65, doi. 10.1111/hiv.12532
    By:
    • Pett, S. L.;
    • Amin, J.;
    • Horban, A.;
    • Andrade‐Villanueva, J.;
    • Losso, M.;
    • Porteiro, N.;
    • Madero, J. S.;
    • Belloso, W.;
    • Tu, E.;
    • Silk, D.;
    • Kelleher, A.;
    • Harrigan, R.;
    • Clark, A.;
    • Sugiura, W.;
    • Wolff, M.;
    • Gill, J.;
    • Gatell, J.;
    • Clarke, A.;
    • Ruxrungtham, K.;
    • Prazuck, T.
    Publication type:
    Article
    44

    Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

    Published in:
    HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
    By:
    • Poveda, E;
    • Hernández‐Quero, J;
    • Pérez‐Elías, MJ;
    • Ribas, MA;
    • Martínez‐Madrid, OJ;
    • Flores, J;
    • Navarro, J;
    • Gutiérrez, F;
    • García‐Deltoro, M;
    • Imaz, A;
    • Ocampo, A;
    • Artero, A;
    • Blanco, F;
    • Bernal, E;
    • Pasquau, J;
    • Mínguez‐Gallego, C;
    • Pérez, N;
    • Aiestaran, A;
    • García, F;
    • Paredes, R
    Publication type:
    Article
    45
    46
    47
    48
    49
    50